Your browser doesn't support javascript.
loading
Population size mediates the contribution of high-rate and large-benefit mutations to parallel evolution.
Schenk, Martijn F; Zwart, Mark P; Hwang, Sungmin; Ruelens, Philip; Severing, Edouard; Krug, Joachim; de Visser, J Arjan G M.
Afiliación
  • Schenk MF; Laboratory of Genetics, Wageningen University and Research, Wageningen, the Netherlands.
  • Zwart MP; Wageningen Food Safety Research, Wageningen, the Netherlands.
  • Hwang S; Laboratory of Genetics, Wageningen University and Research, Wageningen, the Netherlands. M.Zwart@nioo.knaw.nl.
  • Ruelens P; Institute for Biological Physics, University of Cologne, Cologne, Germany. M.Zwart@nioo.knaw.nl.
  • Severing E; Netherlands Institute of Ecology, Wageningen, the Netherlands. M.Zwart@nioo.knaw.nl.
  • Krug J; Institute for Biological Physics, University of Cologne, Cologne, Germany.
  • de Visser JAGM; Capital Fund Management, Paris, France.
Nat Ecol Evol ; 6(4): 439-447, 2022 04.
Article en En | MEDLINE | ID: mdl-35241808
Mutations with large fitness benefits and mutations occurring at high rates may both cause parallel evolution, but their contribution is predicted to depend on population size. Moreover, high-rate and large-benefit mutations may have different long-term adaptive consequences. We show that small and 100-fold larger bacterial populations evolve resistance to a ß-lactam antibiotic by using similar numbers, but different types of mutations. Small populations frequently substitute similar high-rate structural variants and loss-of-function point mutations, including the deletion of a low-activity ß-lactamase, and evolve modest resistance levels. Large populations more often use low-rate, large-benefit point mutations affecting the same targets, including mutations activating the ß-lactamase and other gain-of-function mutations, leading to much higher resistance levels. Our results demonstrate the separation by clonal interference of mutation classes with divergent adaptive consequences, causing a shift from high-rate to large-benefit mutations with increases in population size.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Beta-Lactamasas / Antibacterianos Idioma: En Revista: Nat Ecol Evol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Beta-Lactamasas / Antibacterianos Idioma: En Revista: Nat Ecol Evol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos